Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 13 Feb 2026 for Pacira BioSciences, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Kristen Williams: trading record in brief
Kristen Williams, listed as senior executive, appears in our data through filings on Pacira BioSciences, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 5 February 2024 to 11 February 2026, the count stands at 7 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 13 February 2026: a share grant, in Pacira BioSciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Kristen Williams
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
54,546 shares0Common StockSEC:0001628280-26-008078:0
17,134 shares@ US$20.540.028% mcap50.0% of flowCommon StockSEC:0001628280-26-005157:0
6,162 shares@ US$26.4027.4% of flowCommon StockSEC:0001396814-25-000068:0
79,200 shares0Common StockSEC:0001396814-25-000032:0
54,300 shares0Common StockSEC:0001396814-24-000074:0
3,011 shares@ US$30.8912.7% of flowCommon StockSEC:0001396814-24-000053:0
33,700 shares0Common StockSEC:0001396814-24-000018:0
7 of 7 declarations
